HER2 NEGATIVE BREAST NEOPLASMS

Clinical trials for HER2 NEGATIVE BREAST NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new HER2 NEGATIVE BREAST NEOPLASMS trials appear

Sign up with your email to follow new studies for HER2 NEGATIVE BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Terminated 1

New cancer drug trial tests experimental treatment for multiple tumor types

Disease control Recruiting now

This early-stage trial is testing an experimental drug called sigvotatug vedotin for people with advanced solid tumors that have spread or cannot be removed by surgery. The study will first determine safe doses, then test the drug alone and in combination with other cancer medica…

Matched conditions: HER2 NEGATIVE BREAST NEOPLASMS

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

HER2 NEGATIVE BREAST NEOPLASMS

Get alerted when new HER2 NEGATIVE BREAST NEOPLASMS trials appear

New cancer drug trial tests experimental treatment for multiple tumor types